HOVON 134 (R/R)

HOVON 134 (R/R)

A phase II trial in patients with myelofibrosis (primary, post-ET or post PV-MF) treated with the selective JAK2 inhibitor pacritinib before reduced-intensity conditioning allogeneic stem cell transplantation


Study treatments

Induction treatment with pacritinib


Inclusion criteria


Exclusion criteria


Participating sites



Link